Fixed drug eruption related to sunitinib: a case report.

Fixed drug eruption related to sunitinib: a case report.
Dermatol Online J. 2018 Jun 15;24(6):
Authors: Bhatia A, Jha N, Kanish B
Abstract
Sunitinib is an oral multi-targeted tyrosine kinase inhibitor. It has been approved for the treatment of gastro-intestinal stromal tumor and advanced renal cell carcinoma. Fixed drug eruption related to sunitinib is a rare cutaneous adverse drug reaction.
PMID: 30142719 [PubMed - in process]

Source: Dermatol Online J - June 15, 2018 Category: Dermatology Authors: Bhatia A, Jha N, Kanish B Tags: Dermatol Online J Source Type: research